Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Follicular 1Leukemia 1Graft vs Host Disease 1Asthma 1

Interventions

Methotrexate 10Cyclophosphamide 8Cyclosporine 6Tacrolimus 4Mycophenolic Acid 4Sirolimus 3Antilymphocyte Serum 3fludarabine 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Pentostatin 2Methylprednisolone 2Cyclosporins 2Busulfan 2trihexyltetradecylphosphonium chloride 1thymoglobulin 1ruxolitinib 1merphos 1ibrutinib 1fludarabine phosphate 1aldesleukin 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1Rituximab 1Proto-Oncogene Proteins c-raf 1Prednisone 1Photopheresis 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Graft vs Host Disease × Budesonide × Clear all
NCT00180089 2010-03-30

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

Technische Universität Dresden

Phase 3 Completed
242 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡